Detalles de la búsqueda
1.
Discovery and In Vitro Characterization of BAY 2686013, an Allosteric Small Molecule Antagonist of the Human Pituitary Adenylate Cyclase-Activating Polypeptide Receptor.
Mol Pharmacol
; 104(3): 105-114, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37348913
2.
Discovery of YAP1/TAZ pathway inhibitors through phenotypic screening with potent anti-tumor activity via blockade of Rho-GTPase signaling.
Cell Chem Biol
; 2024 Mar 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38537632
3.
Discovery and Characterization of BAY 1214784, an Orally Available Spiroindoline Derivative Acting as a Potent and Selective Antagonist of the Human Gonadotropin-Releasing Hormone Receptor as Proven in a First-In-Human Study in Postmenopausal Women.
J Med Chem
; 63(20): 11854-11881, 2020 10 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-32960053
4.
Discovery of BAY-298 and BAY-899: Tetrahydro-1,6-naphthyridine-Based, Potent, and Selective Antagonists of the Luteinizing Hormone Receptor Which Reduce Sex Hormone Levels in Vivo.
J Med Chem
; 62(22): 10321-10341, 2019 11 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-31670515
5.
Discovery and Characterization of the Potent and Highly Selective (Piperidin-4-yl)pyrido[3,2- d]pyrimidine Based in Vitro Probe BAY-885 for the Kinase ERK5.
J Med Chem
; 62(2): 928-940, 2019 01 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-30563338
6.
Novel Class of Potent and Cellularly Active Inhibitors Devalidates MTH1 as Broad-Spectrum Cancer Target.
ACS Chem Biol
; 12(8): 1986-1992, 2017 08 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-28679043
7.
Characterization of 12 GnRH peptide agonists - a kinetic perspective.
Br J Pharmacol
; 173(1): 128-41, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26398856
Resultados
1 -
7
de 7
1
Próxima >
>>